MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q2
hinzugefügt 16.05.2026
Syneos Health EV 2011-2026 | SYNH
EV Jährlich Syneos Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.59 B | 14.1 B | 12.3 B | 10.6 B | 9.52 B | 6.81 B | 3.75 B | 3.35 B | 1.96 B | 860 M | 859 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 14.1 B | 859 M | 6.25 B |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 203.78 | -0.37 % | $ 22.6 B | USA |
 |
Celcuity
CELC
|
5.57 B | $ 88.24 | -4.7 % | $ 4.13 B | USA |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-1.92 M | $ 4.88 | 8.44 % | $ 6.49 M | USA |
 |
Fulgent Genetics
FLGT
|
583 M | $ 18.93 | 2.32 % | $ 583 M | USA |
 |
Castle Biosciences
CSTL
|
463 M | $ 21.08 | - | $ 611 M | USA |
 |
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
69.5 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
ICON Public Limited Company
ICLR
|
16.5 B | $ 144.59 | -4.76 % | $ 11.3 B |  Irlanda |
 |
Illumina
ILMN
|
23.8 B | $ 162.47 | 1.52 % | $ 25.2 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
15.2 B | $ 130.7 | 0.45 % | $ 16.4 B | USA |
 |
CareDx, Inc
CDNA
|
1.04 B | $ 23.46 | 3.12 % | $ 1.25 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-2 K | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
16.3 M | $ 1.76 | 1.32 % | $ 7.79 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
-2.71 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
3.34 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
654 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
5.9 B | $ 100.24 | 0.26 % | $ 6.77 B | USA |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 186.29 | -1.88 % | $ 9.23 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.37 | - | $ 411 M | USA |
 |
Medpace Holdings
MEDP
|
14 B | $ 465.73 | -0.23 % | $ 13.4 B | USA |
 |
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
32.1 B | $ 1 133.03 | -2.58 % | $ 23.4 B |  Schweiz |
 |
NeoGenomics
NEO
|
1.85 B | $ 11.28 | -1.4 % | $ 1.44 B | USA |
 |
Myriad Genetics
MYGN
|
598 M | $ 4.43 | -2.42 % | $ 410 M | USA |
 |
National Research Corporation
NRC
|
432 M | $ 21.28 | 7.75 % | $ 476 M | USA |
 |
Natera
NTRA
|
30.1 B | $ 216.5 | -2.84 % | $ 29.6 B | USA |
 |
Personalis
PSNL
|
380 M | $ 9.61 | -1.44 % | $ 858 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
43.5 B | $ 25.67 | -3.13 % | $ 24.3 B |  Niderland |
 |
Senseonics Holdings
SENS
|
376 M | $ 7.3 | -1.75 % | $ 305 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
2.13 B | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
6.63 M | $ 2.02 | -1.51 % | $ 4.64 M | USA |
 |
Twist Bioscience Corporation
TWST
|
1.55 B | $ 67.77 | -3.27 % | $ 4.05 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 268.63 | -0.96 % | $ 22.4 B | USA |
 |
Thermo Fisher Scientific
TMO
|
186 B | $ 482.04 | -2.43 % | $ 182 B | USA |
 |
Trinity Biotech plc
TRIB
|
327 M | $ 0.69 | 3.51 % | $ 248 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 9.17 | -1.29 % | $ 1.99 B | USA |
 |
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | USA |